MTOR and breast cancer: One recent study demonstrated that CEBPD directly inhibits expression of the tumor suppressor FBXW7, resulting in a consequent enhancement of mTOR/AKT/S6K1 signaling, which further suggests CEBPD is necessary for metastatic progression of mammary tumors [11].